Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity. |
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
ZtY3ZcVM63XxQtYJ
Listen
